期刊文献+

MMP-9 uPA在大肠癌中的表达及临床意义 被引量:4

Expressions and Clinical Significance of MMP-9 and uPA in Colorectal Carcinoma
暂未订购
导出
摘要 目的研究MMP-9、uPA在大肠癌中的表达及其意义。方法应用免疫组化SP法检测50例大肠癌、11例正常大肠黏膜标本中MMP-9、uPA蛋白的表达情况。结果MMP-9和uPA蛋白在大肠癌组的阳性表达显著高于正常大肠黏膜组,并与大肠癌的组织学分级、浸润深度、淋巴结转移、远处转移密切相关(P<0.05)。且两者表达呈正相关(P<0.05)。结论MMP-9、uPA的高表达预示着大肠癌的低分化、并共同促进了肿瘤的侵袭、转移。联合检测MMP-9、uPA的表达情况对于评估大肠癌的发展及预后具有重要意义。 Objective To explore the expression and clinical significance of MMP -9 and uPA protein in colorectal cancer. Methods The expressions of MMP -9 and uPA protein were detected in 50 cases of carcinomas, 11 cases of normal colorectal mucosas by a streptavidin - peroxidase (SP) technique. Results The positive expressions of MMP -9 and uPA protein in colorectal carcinomas were significantly higher than those in normal colorectal mucosas, and were related with histological grades, the depth of invasion, lymph node metastasis, distant metastasis (P 〈 0. 05) . A positive correlation was observed between the expression of MMP - 9 and that of uPA ( P 〈 0. 05 ). Conclusion Overexpression of MMP - 9 and uPA in colorectal carcinoma were associated with poorly histological grades, cell migration, tumor metastases and poor prognosis. It is very significant to investigate the expression of MMP -9 and uPA combinodly in colorectal carcinoma.
出处 《医药论坛杂志》 2008年第5期22-23,26,共3页 Journal of Medical Forum
基金 河南省医学科技攻关计划项目(编号2006065)
关键词 MMP-9 UPA 大肠癌 免疫组织化学 MMP - 9 uPA Colorectal carcinoma Immunohistochemistry
  • 相关文献

参考文献6

二级参考文献15

  • 1Tyler ZARUBIN.Activation and signaling of the p38 MAP kinase pathway[J].Cell Research,2005,15(1):11-18. 被引量:158
  • 2Kohn EC,Liotta L.Molecular insights into cancer invision:strategies for prevention and intervention[J].Cancer Res,1995,55(9):1856-1862.
  • 3Dano K,Andreasen P,Skriver L.Plasminogen activators,tissue degradation and cancer[J].Adv Cancer Res,1985,44:139-266.
  • 4Hoffmann G,Pollow K,Weikel W,et al.UPA and PAI1 status in primary ovarian carcinomas and ovarian metastases compared to benign ovarian tumors as a function of histopathological parameters[J].Clin Chem Lab Med,1999,37(1):47-54.
  • 5Konecny G,Untch M,Pihan A,et al.Association of urokinase -type plasminogen activators and its inhibitor with disease progression and Prosnosis in ovarian cancer[J].Clin Cancer Bes,2001,7(6):1743-1749.
  • 6Foekens JA,Peters HA,Look MP,et al.The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients[J].Cancer Res,2000,60(3):636-643.
  • 7Hansen S,Overgaard J,Rose C,et al.Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patients[J].Br J Cancer,2003,88(1):102-108.
  • 8Shin SJ,Kim KO,Kim MK,et al.Expression of E-cadherin and UPA and their association with the prognosis of pancreatic cancer[J].Jpn J Clin Oncol,2005,35(6):342-348.
  • 9郜恒骏,于连珍,孙亮,缪琨,白剑峰,张小勇,吕秀珍,赵志泉.胃癌及癌旁组织中COX-2基因蛋白的表达[J].世界华人消化杂志,2000,8(5):578-579. 被引量:29
  • 10张俊,刘炳亚,林言箴.有关国际抗癌联合会与日本胃癌各分期法之说明[J].外科理论与实践,2000,5(3):204-204. 被引量:8

共引文献39

同被引文献42

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部